Launching 2027
The definitive path from innovation to access.
Waypoint Access is a fractional market access consultancy for medical technology and life-science innovators — turning evidence into coverage, reimbursement and real-world adoption.
Request early accessOur expertise
Every milestone, mapped.
Coverage & Reimbursement
Coding, coverage and payment strategy that secures payer access across commercial and government markets.
Health Economics & HEOR
Value dossiers, budget-impact and cost-effectiveness models that prove economic utility.
Evidence Strategy
Clinical trial design, publications and KOL engagement that build scientific credibility.
Regulatory Pathways
510(k), PMA, IDE and EU MDR strategy aligned with downstream access from day one.
Pricing & Launch
Pricing, go-to-market roadmaps and commercialization planning for a confident launch.
Fractional Leadership
Seasoned access executives who embed with your team and influence boards and investors.
ELIMINATE AMBIGUITY
Not every advisor sees the road ahead. Ours do.
Clarity from experience
Experts who see clearly.
Coverage policy, coding and payer evidence standards shift constantly. Less experienced advisors guess at the terrain. Our senior team has guided hundreds of devices and therapies through CMS, commercial payers and HTA bodies — we know the route because we've walked it.
The entire picture
Experts who see everything.
A narrow focus on one milestone — a 510(k), a single code, one trial — leaves costly blind spots. We connect regulatory, clinical evidence, HEOR, pricing and reimbursement into one integrated strategy, so every decision moves you toward coverage and adoption.
Be first in line
Start your access strategy early.
Leave your details and a senior advisor will reach out as we open our doors.